Trastuzumab Rezetecan vs Trastuzumab Deruxtecan in the Neoadjuvant Treatment of HER2 Positive Breast Cancer

NCT07416253 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

68

Enrollment

OTHER_GOV

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Trastuzumab rezetecan
DRUG: Trastuzumab deruxtecan

Sponsor

Henan Cancer Hospital